Rare Disease Therapeutics

Part of Biotech - Drug Development
AMGNAMGNAmgen Inc$249.4b$466.56+0.1%634.5K
VRTXVRTXVertex Pharmaceuticals Inc$134.5b$535.57-0.3%397.8K
UTHRUTHRUnited Therapeutics Corp$25.8b$585.82-0.8%174.4K
INCYINCYIncyte Genomics Inc$24.0b$120.21-0.6%488.4K
INSMINSMInsmed, Inc.$22.9b$123.65+1.8%1.3M
ALNYALNYAlnylam Pharmaceuticals, Inc.$21.4b$160.18-2.8%914.8K
BBIOBBIOBridgeBio Pharma, Inc. Common Stock$14.4b$77.05-1.6%473.7K
BMRNBMRNBioMarin Pharmaceuticals Inc$10.8b$58.07+1.3%606.5K
KRYSKRYSKrystal Biotech, Inc. Common Stock$9.0b$297.13-2.4%64.7K
CORTCORTCorcept Therapeutics Inc.$8.9b$69.15-5.6%426.5K
CRNXCRNXCrinetics Pharmaceuticals, Inc.$8.8b$84.970.0%N/A
CYTKCYTKCytokinetics Inc.$8.7b$53.09-4.9%604.2K
ARWRARWRArrowhead Research Corporation$8.4b$44.91-5.7%773.8K
IONSIONSIonis Pharmaceuticals, Inc. Common Stock$6.7b$28.30-1.6%2.4M
RYTMRYTMRhythm Pharmaceuticals, Inc. Common Stock$6.0b$108.41-5.5%486.0K
PTCTPTCTPTC Therapeutics, Inc.$5.7b$61.64-2.6%181.5K
MIRMMIRMMirum Pharmaceuticals, Inc. Common Stock$5.7b$93.11-1.0%210.4K
COGTCOGTCogent Biosciences, Inc. Common Stock$5.4b$27.38-4.5%607.3K
SRRKSRRKScholar Rock Holding Corporation Common Stock$5.4b$43.00-0.4%905.5K
APLSAPLSApellis Pharmaceuticals, Inc. Common Stock$5.2b$41.04+0.0%68.6M
CRSPCRSPCRISPR Therapeutics AG$4.8b$40.78-3.5%821.5K
TVTXTVTXTravere Therapeutics, Inc. Common Stock$4.7b$49.84-1.5%386.6K
FOLDFOLDAmicus Therapeutics, Inc$4.5b$14.49+0.0%3.5M
EWTXEWTXEdgewise Therapeutics, Inc. Common Stock$4.1b$43.64-4.7%515.8K
CPRXCPRXCatalyst Pharmaceutical Inc.$3.8b$31.510.0%N/A
LQDALQDALiquidia Corporation Common Stock$3.8b$56.60-1.5%949.3K
AMLXAMLXAmylyx Pharmaceuticals, Inc. Common Stock$3.7b$28.57-5.9%683.8K
IRONIRONDisc Medicine, Inc. Common Stock$3.6b$77.70-2.7%322.0K
TARSTARSTarsus Pharmaceuticals, Inc. Common Stock$3.4b$78.05-2.7%267.6K
DYNDYNDyne Therapeutics, Inc. Common Stock$3.4b$16.52-3.7%739.1K
VRDNVRDNViridian Therapeutics, Inc. Common Stock$2.8b$30.32-1.5%801.3K
SLNOSLNOSoleno Therapeutics, Inc. Common Stock$2.7b$53.02+0.0%1.6M
BEAMBEAMBeam Therapeutics Inc. Common Stock$2.7b$21.32-6.3%1.2M
PHVSPHVSPharvaris N.V. Ordinary Shares$2.4b$32.86-2.2%161.8K
COAGCOAGHemab Therapeutics Holdings, Inc. Common Stock$2.3b$40.17-1.3%189.7K
AUPHAUPHAurinia Pharmaceuticals Inc$2.2b$15.43-1.8%382.5K
PVLAPVLAPalvella Therapeutics, Inc. Common Stock$2.2b$147.74-3.4%109.6K
BCRXBCRXBioCryst Pharmaceuticals Inc$2.2b$7.50-1.4%1.4M
HRMYHRMYHarmony Biosciences Holdings, Inc. Common Stock$2.2b$33.17-1.7%326.1K
SRPTSRPTSarepta Therapeutics,, Inc. Common Stock$2.0b$15.20-5.6%821.8K
XERSXERSXeris Biopharma Holdings, Inc. Common Stock$1.9b$16.67-0.1%1.2M
AGIOAGIOAgios Pharmaceuticals, Inc.$1.9b$30.49-3.1%156.3K
STOKSTOKStoke Therapeutics, Inc. Common Stock$1.7b$26.56-0.3%166.2K
NTLANTLAIntellia Therapeutics, Inc$1.7b$9.89+1.9%3.4M
ANIPANIPANI Pharmaceuticals, Inc.$1.7b$70.79-0.6%90.8K
QUREQUREuniQure N.V.$1.7b$22.03-7.2%370.1K
RARERAREUltragenyx Pharmaceutical Inc.$1.6b$15.91-1.0%1.8M
FBRXFBRXForte Biosciences, Inc. Common Stock$1.6b$76.980.0%N/A
OCULOCULOcular Therapeutix, Inc.$1.5b$6.03-4.2%1.7M
ETONETONEton Pharmaceutcials, Inc. Common Stock$1.5b$64.38+0.9%278.1K

Explore Similar Themes